Step 6:

Virtual Visits & Support

Bringing real-time support and trial visits directly to patients—anytime, anywhere.

ObvioGo enables secure, real-time interactions between study teams and participants—reducing the need for in-person visits while maintaining compliance and protocol fidelity. By supporting decentralized interactions, we help sponsors deliver flexible, scalable trials with improved retention and data accuracy.

Smarter Support. Lower Costs. Higher Retention.

ObvioGo simplifies patient interactions with virtual visits and built-in support—reducing the need for in-person visits while boosting flexibility, improving retention, and increasing site efficiency through smarter, real-time engagement tools.

Minimize In-Person Requirements

ObvioGo helps reduce reliance on on-site visits and minimizes SDV burden by serving as a validated eSource. Real-time data capture within the platform lowers site workload, decreases monitoring costs, and gives sponsors continuous visibility into participant progress—enabling faster issue resolution without manual data reconciliation.

Fewer On-Site Visits

Reduce reliance on traditional site-based appointments with virtual visits and remote data collection, easing burdens on both patients and site staff.

More Efficient Monitroing

Real-time access to participant data allows study teams to reduce the frequency and duration of remote monitoring visits—minimizing disruptions and costs.

Compliance by Design

Virtual interactions are securely logged, time-stamped, and user-attributed—supporting inspection readiness and alignment with global data privacy standards

Less Monitoring, More Efficiency

With continuous access to real-time participant data via ObvioGo’s validated eSource, remote monitoring visits can occur less frequently and take less time. Study teams gain the visibility needed to resolve issues faster—without manual data reconciliation or delays in oversight. By minimizing administrative burden, ObvioGo empowers clinical teams to focus on patient engagement and trial quality.

Real-Time Oversight

Gain immediate visibility into participant progress, protocol adherence, and data completion—enabling faster, more proactive support and decision-making.

Streamlined Workflows

Automated alerts and task tracking reduce manual coordination between sites, monitors, and participants, improving efficiency and minimizing delays.

Smarter Monitoring Strategies

Continuous access to live data reduces the need for frequent remote visits and allows for targeted, risk-based monitoring—saving time and resources while maintaining compliance.

In-App Support that Drives Engagement

ObvioGo provides real-time, in-app support to keep participants informed and engaged. With live chat, reminders, and task guidance, participants get help when they need it—reducing confusion, improving adherence, and giving study teams clearer visibility into patient needs without manual follow-up.

With fewer dropouts and cleaner, real-time data, sponsors get stronger evidence—faster.

Simplifying Trials for Everyone

Integrated Virtual Infrastructure

ObvioGo supports seamless telehealth visits, in-app chat, and asynchronous data capture—all built into a single, compliant platform.

Always-On Access

Study teams can monitor participant progress in real time, resolve issues faster, and support decentralized trials without site coordination delays.

Designed for Sites and Sponsors

Our workflows reduce burdens on both site staff and monitors, while offering sponsors transparent oversight, centralized visit data, and inspection-readiness at every step.

Need proof? Hear it from our participants.

“I had all my questions answered. It was simple.”​

Trial Participant

“The entire process was very simple and easy to navigate.”​​

Trial Participant

“I sent a thank you note when I was done, because I felt like I had a kind of personal relationship with the staff.”​

Trial Participant

"It was pretty much seamless from the start. From scheduling the whole appointment and the contact, there was always help from the research team.”​

Trial Participant

​“I have been involved in other studies where I carried around their study device. Having the app on my phone and just one device, made it so much easier ”​

Trial Participant

“I would just get the notification and then go to the app and answer the survey questions. They had a screening questionnaire, and it was just easy to just go through and mark my answer, go to the next activity and hit submit.”​

Trial Participant

“I had all my questions answered. It was simple.”​

Trial Participant

“The entire process was very simple and easy to navigate.”​​

Trial Participant

“I sent a thank you note when I was done, because I felt like I had a kind of personal relationship with the staff.”​

Trial Participant

"It was pretty much seamless from the start. From scheduling the whole appointment and the contact, there was always help from the research team.”​

Trial Participant

​“I have been involved in other studies where I carried around their study device. Having the app on my phone and just one device, made it so much easier ”​

Trial Participant

“I would just get the notification and then go to the app and answer the survey questions. They had a screening questionnaire, and it was just easy to just go through and mark my answer, go to the next activity and hit submit.”​

Trial Participant

“I had all my questions answered. It was simple.”​

Trial Participant

“The entire process was very simple and easy to navigate.”​​

Trial Participant

“I sent a thank you note when I was done, because I felt like I had a kind of personal relationship with the staff.”​

Trial Participant

"It was pretty much seamless from the start. From scheduling the whole appointment and the contact, there was always help from the research team.”​

Trial Participant

​“I have been involved in other studies where I carried around their study device. Having the app on my phone and just one device, made it so much easier ”​

Trial Participant

“I would just get the notification and then go to the app and answer the survey questions. They had a screening questionnaire, and it was just easy to just go through and mark my answer, go to the next activity and hit submit.”​

Trial Participant